title: Effects of acute administration of natural progesterone on peripheral vascular responsiveness in healthy postmenopausal women.
abstract: Peripheral vascular responses to acute administration of natural progesterone were studied in 12 postmenopausal women (mean +/- SD age 50.3 +/- 4.8 years) with no evidence of cardiovascular disease. According to a randomized, double-blind protocol, all subjects were given natural progesterone as a vaginal cream, able to produce a rapid peak and decay of plasma hormone concentrations, or matched placebo, with crossover after a 1-week washout period. Forearm blood flow and peak flow after ischemic stress (ml/100 ml/min), local vascular resistance (mm Hg/ml/100 ml/min), venous volume (ml/100 ml), and venous compliance (ml/100 ml/mm Hg) were measured by strain-gauge venous occlusion plethysmography at baseline and after progesterone or placebo administration. Plasma norepinephrine concentrations were determined by high-performance liquid chromatography with electrochemical detection. Progesterone sharply decreased forearm blood flow (p <0.01) through an increase in local vascular resistance (p <0.01). Measures of venous function remained unchanged. Although the hormone increased circulating norepinephrine concentrations (p <0.05), there were no significant changes in mean arterial pressure or heart rate. Furthermore, progesterone reduced the local vasodilator capacity, shown by a decrease in forearm delta flow (difference between peak flow and basal flow, p <0.05). Compared with the well-known effect of estrogen, progesterone exerted an opposite action on peripheral vascular responsiveness. Peripheral circulatory changes may be attributed to a direct activity of progesterone on the arterial wall and may in part reflect a modulation of the hormone on peripheral sympathetic tone. Consideration must be given to the hypothesis that the addition of progestin may attenuate the beneficial effects of unopposed estrogen replacement therapy in postmenopausal women.
authors.affiliation: Institute of Cardiology and Department of Obstetrics and Gynecology, University of Cagliari, Sardinia, Italy. mercuro@pacs.unica.it
authors.forename: G
authors.initials: G
authors.lastname: Mercuro
authors.forename: L
authors.initials: L
authors.lastname: Pitzalis
authors.forename: A
authors.initials: A
authors.lastname: Podda
authors.forename: S
authors.initials: S
authors.lastname: Zoncu
authors.forename: I
authors.initials: I
authors.lastname: Pilia
authors.forename: G B
authors.initials: GB
authors.lastname: Melis
authors.forename: A
authors.initials: A
authors.lastname: Cherchi
mesh_terms: D002320:Cardiovascular Physiological Phenomena / Q000187:drug effects*; D004311:Double-Blind Method; D005260:Female; D006439:Hemodynamics; D006801:Humans; D008875:Middle Aged; D017698:Postmenopause / Q000097:blood*; D011374:Progesterone / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*
chemical_list: D011374:Progesterone